Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature

Background: pediatric patients with inflammatory bowel diseases (IBD) who qualify for biological therapy represent a group of severely ill patients. They have never been successful with conventional medication. Biologic medications in monotherapy are frequently used in the disease course, however th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wlazło, Magdalena, Kierkuś, Jarosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000175/
https://www.ncbi.nlm.nih.gov/pubmed/35407612
http://dx.doi.org/10.3390/jcm11072004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000175/
https://www.ncbi.nlm.nih.gov/pubmed/35407612
http://dx.doi.org/10.3390/jcm11072004

Ejemplares similares